[Guideline. Immunologic infertility].
Krause
Walter
W
Zentrum für Hautkrankheiten, Philipps-Universitäts Marburg. krause@mailer.uni-marburg.de
D001323:Autoantibodies / Q000276:immunology; D002582:Cervix Mucus / Q000276:immunology; D003167:Complement Activation; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007159:Immunologic Tests; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007246:Infertility / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D007247:Infertility, Female / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000628:therapy; D007248:Infertility, Male / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000628:therapy; D008297:Male; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D027724:Reproductive Techniques, Assisted; D012307:Risk Factors; D012737:Sex Factors; D020554:Sperm Injections, Intracytoplasmic; D013094:Spermatozoa / Q000276:immunology*
D001323:Autoantibodies; D005938:Glucocorticoids; D007166:Immunosuppressive Agents